Sphera Funds Management’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-328,562
| Closed | -$121K | – | 122 |
|
|
2025
Q2 | $121K | Sell |
328,562
-30,000
| -8% | -$10K | 0.03% | 107 |
|
|
2025
Q1 | $92.9K | Sell |
358,562
-660,000
| -65% | -$377K | 0.02% | 112 |
|
|
2024
Q4 | $573K | Sell |
1,018,562
-61,200
| -6% | -$36.1K | 0.11% | 101 |
|
|
2024
Q3 | $648K | Buy |
1,079,762
+749,762
| +227% | +$1.11M | 0.11% | 104 |
|
|
2024
Q2 | $891K | Sell |
330,000
-100,000
| -23% | -$377K | 0.15% | 106 |
|
|
2024
Q1 | $2.21M | Sell |
430,000
-470,000
| -52% | -$1.52M | 0.36% | 73 |
|
|
2023
Q4 | $483K | Hold |
900,000
| – | – | 0.09% | 91 |
|
|
2023
Q3 | $596K | Hold |
900,000
| – | – | 0.14% | 79 |
|
|
2023
Q2 | $1.37M | Buy |
+900,000
| New | +$2.37M | 0.29% | 79 |
|
|
2021
Q3 | – | Sell |
-30,000
| Closed | -$407K | – | 128 |
|
|
2021
Q2 | $407K | Buy |
+30,000
| New | +$371K | 0.04% | 129 |
|
